Uva ursi (Arctostaphylos uva-ursi)
EMA-registered traditional herbal leaf for short-term relief of uncomplicated lower UTI symptoms in women, based on long-standing use rather than trials.
- Evidence
- Traditional useGRADE certainty: Very low
- Typical dose
- Standardised extract delivering 400–800 mg arbutin/day, divided
- Time to effect
- Symptom reduction within 1–3 days
- Safety
- Has documented cautions
Evidence ratings summarise published research on Uva ursi (Arctostaphylos uva-ursi) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Uva ursi (Arctostaphylos uva-ursi)
Interactions
Taking any medication?
Check Uva ursi (Arctostaphylos uva-ursi) against it.
Why
Uva ursi (Arctostaphylos uva-ursi) leaf holds an EMA HMPC monograph at Traditional Use for short-term relief of symptoms of uncomplicated lower urinary tract infections in women, such as burning sensation during urination and frequent micturition, after serious conditions have been excluded by a clinician. A German guideline says it can be considered as a non-antibiotic option in non-geriatric adults with acute uncomplicated cystitis after shared decision-making, for no longer than one month. It is not a substitute for antibiotics. Limited to short courses due to hydroquinone metabolite concerns.
How it works
Arbutin and methylarbutin are hydrolysed in alkaline urine to hydroquinone, which has direct antibacterial activity against uropathogens. Alkalisation of urine (e.g. with sodium bicarbonate) was historically combined with uva ursi to optimise hydroquinone release.
Expected onset · Symptom reduction within 1–3 days
How to take
Dosage
Standardised extract delivering 400–800 mg arbutin/day, divided. Limit course to 7 days; no more than 5 episodes per year.
Timing
Three or four times daily during acute episode
On the label
Standardised extract with stated arbutin content (10–12% in leaf). Avoid leaf extracts without standardisation.
Studied in
Adult women with mild symptoms of acute uncomplicated lower UTI, after discussion with a clinician.
Safety
Evidence
Registered by the EMA as a traditional herbal medicine for short-term relief of symptoms of uncomplicated lower urinary tract infections in women (long-standing use, not clinical trials). The German AWMF guideline (2024) says uva ursi can be considered as an alternative to antibiotics in non-geriatric adults with acute uncomplicated cystitis after shared decision-making, and not beyond one month.
GRADE certainty: Very low — EMA traditional use (long-standing use, not trials)
Questions people ask
Does Uva ursi (Arctostaphylos uva-ursi) work?
Registered by the EMA as a traditional herbal medicine for short-term relief of symptoms of uncomplicated lower urinary tract infections in women (long-standing use, not clinical trials). The German AWMF guideline (2024) says uva ursi can be considered as an alternative to antibiotics in non-geriatric adults with acute uncomplicated cystitis after shared decision-making, and not beyond one month. Certainty of the evidence: Very low, EMA traditional use (long-standing use, not trials).
How is Uva ursi (Arctostaphylos uva-ursi) taken?
Standardised extract delivering 400–800 mg arbutin/day, divided. Limit course to 7 days; no more than 5 episodes per year. Timing: Three or four times daily during acute episode. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Limit to 7 days per course and no more than 5 courses per year. Hydroquinone is potentially genotoxic at high cumulative exposure. Not for chronic prevention. Avoid in pregnancy, breastfeeding, kidney disease, and children under 12. Caution with NSAIDs (uricosuric interaction). Blood in the urine, fever, flank pain or feeling systemically unwell need prompt medical care rather than herbal treatment. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EMA HMPC monograph, Arctostaphylos uva-ursi (L.) Spreng., folium (Traditional Use); AWMF guideline (2024): S3-Leitlinie Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen (HWI), AWMF 043-044.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.